Irfan Qureshi

Title: Irfan Qureshi: Innovator in Pharmaceutical Advancements

Introduction

Irfan Qureshi is a notable inventor based in Hackensack, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological diseases. With a total of 3 patents, his work has the potential to impact many patients in need of effective therapies.

Latest Patents

One of Irfan Qureshi's latest patents involves the use of riluzole oral disintegrating tablets for treating diseases. This patent discloses methods of treating a disease in a patient by administering a pharmaceutical composition that includes a therapeutically effective amount of riluzole, or a pharmaceutically acceptable salt thereof, in the form of an oral solid molded fast-dispersing dosage form. Additionally, he has developed a patent for the use of riluzole prodrugs to treat Alzheimer's disease. This patent outlines methods of treating Alzheimer's Disease by administering a riluzole prodrug, such as troriluzole, to patients in need.

Career Highlights

Irfan Qureshi is currently associated with Biohaven Therapeutics Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new treatments that can improve the quality of life for patients suffering from various diseases.

Collaborations

Irfan has collaborated with notable professionals in his field, including Vladimir Coric and Robert Berman. These collaborations have further enhanced his research and development efforts.

Conclusion

Irfan Qureshi's contributions to pharmaceutical innovations, particularly in the treatment of neurological diseases, highlight his role as a significant inventor in the industry. His patents reflect a commitment to improving patient care through effective therapies.